CSRXP: FDA APPROVAL AND SUBSEQUENT BIOGEN PRICING OF ADUCANUMAB DEMAND RETROSPECTION, REFORM
Troubling for Public Health Institution to Depart from Established Norms to… Read More
Troubling for Public Health Institution to Depart from Established Norms to… Read More
Campaign Calls for Promises Made to the American People to Lower Prescription… Read More
Administration and Congress Must Work Together To Pass Solutions to Hold Big… Read More
Holding Big Pharma Accountable Remains Top Priority for American Voters… Read More
Congress and the Administration Must Act on Solutions that Have Won Bipartisan… Read More
Lawmakers Pass Pair of Bills Aimed at Boosting Generic and Biosimilar… Read More
Campaign Will Highlight Impact of Out-of-Control Drug Prices, Especially in… Read More
Government Report Finds No Relationship Between Drug Company R&D and… Read More
Legislation Will Boost Transparency to Hold Big Pharma Accountable for… Read More
Campaign Looks Forward to Working with Secretary Becerra to Lower Drug Prices… Read More
Big Pharma CFO Hypes “Significant Opportunity” From “Pricing… Read More
Big Pharma Has Already Repeatedly Hiked Drug Prices During Public Health… Read More